Akorn gets warning letter from the FDA

(Reuters) – Akorn Inc said on Wednesday it received a warning letter from the U.S. Food and Drug Administration, after the company’s Decatur, Illinois manufacturing facility was inspected by the regulatory authority in April and May, 2018.

The company said it would respond to the FDA letter within 15 working days.

Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by James Emmanuel

Our Standards:The Thomson Reuters Trust Principles.

source: reuters.com

🕐 Top News in the Last Hour By Importance Score (1-100)

#	Title	Score
1	Myanmar earthquake LIVE: Bangkok skyscraper collapses after 8.2 magnitude quake	📊 85
2	Huge 7.7 magnitude earthquake hits Bangkok, DESTROYING apartment block and forcing tourists to flee hotels as 'mass casualty' warning is declared	📊 78
3	Hegseth, facing scandal at home, reaffirms U.S. support for the Philippines against China	📊 78
4	Switching off popular feature on your phone can reverse aging by 10 YEARS	📊 72
5	Fitbit could be working on an ambitious tracker with new technology	📊 72
6	Under-fire Zimbabwe president names new army chief	📊 72
7	Paul O'Grady's tragic final three words shared in emotional video 20 minutes before death	📊 55
8	When Is the Next Solar Eclipse? Where and How to Watch the 2025 Partial Eclipse.	📊 50
9	‘There’s a dangerous epidemic in boxing’: the tragic, cautionary tale of Paul Bamba	📊 45
10	When, where to see the March partial solar eclipse	📊 45

📊 View More Top News ➡️